Bypassing the Blood-Brain-Barrier
Kurve Therapeutics is at the forefront of a new era of central nervous system (CNS) disorder treatments.
We are an innovative specialty-drug and medical technology company focused on developing potential treatments for neurodegenerative diseases. We are working on our patented Controlled Particle Dispersion® intranasal drug delivery platform, a next-generation technology with the aim to reshape the way CNS diseases are treated.
Kurve Therapeutics is taking bold steps to be market-ready — we are preparing to engage with FDA in an End of Phase II meeting to discuss our Phase III program for Alzheimer’s disease.
Find out how you can be a part of our plan for creating impactful change for those suffering from CNS disorders.